20 and Agarwala et al.21 suggest that seminoma patients with adverse prognostic factors, such as non-pulmonary visceral

metastases, short relapse-free survival, and cisplatin-refractory tumors, had less benefit from HDCT. Therefore, Lorch et al.22 developed an international prognostic factors model for germ cell tumor patients who experience treatment failure with cisplatin first-line chemotherapy which might help optimizing the treatment decision in those patients. In another Inhibitors,research,lifescience,medical prospective study,23 patients achieved durable long-term survival after single as well as sequential HDCT, albeit with some toxicity-related deaths. We can conclude that patients with an incomplete response to first-line treatment and those with short relapse-free intervals might profit from early treatment intensification. However, further long-term, prospective studies with large cohorts of patients are needed

to evaluate the role of HDCT in refractory/relapsing AS. Four of our patients demonstrated IGCN in their primary testicular seminoma pathology. Inhibitors,research,lifescience,medical IGCN or carcinoma in situ (CIS) preceded the development of seminoma in adults24 but does not have any effect on prognosis. Morphologically, CIS cells resemble seminoma cells, and cytologically there is no difference between the CIS cells that http://www.selleckchem.com/products/cobimetinib-gdc-0973-rg7420.html transform Inhibitors,research,lifescience,medical into seminomas and those that develop into non-seminomas. The incidence of IGCN is less than 0.3% in the general population but somewhat higher (0.5%) in patients with cryptorchid testes,25 such as three of our patients with IGCN who were cryptorchid. Staging of AS (IIB versus IIC versus IIIA) is important for tailoring appropriate treatment with minimal side effects. Anatomical staging techniques, such as CT scan, intravenous pyelography (IVP), Inhibitors,research,lifescience,medical ultrasound, and lymphangiography, have severe limitations in identifying the exact extension of the lymphadenopathy, with reported false-negative rates of 59% for CT scan and 64% for lymphangiography.26 Enlarged Inhibitors,research,lifescience,medical lymph nodes on CT or filling defects on lymphography are not absolutely

reliable for the diagnosis of AS, and lymphography is not used anymore in the staging of AS. Gallium scan has also been used in AS27 but was not shown to be beneficial in differentiating necrotic tissue from viable seminoma and is currently outdated. Hain et al.26 and Cremerius et al.27 suggest PET-CT techniques for the initial staging through of AS and follow-up of post-chemotherapy residual mass. In its ability to assess metabolic function of tissue through assessing the rate and quantity of tumor uptake of the glucose analogue 2-fluoro-2-deoxyglucose (FDG), PET-CT is a function which can reliably predict the presence or absence of viable tumorous tissue. There were also worrying numbers of false-positive PET results in the initial work-up of seminoma. Hence, the exact role of PET-CT in the initial staging of seminoma should be defined by large, prospective studies.